VIVS
VivoSim Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.28
−0.29%Margins
Gross margin
-134.8%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
-9038.4%
525.9%
Return on equity
-320.7%
Return on assets
558.2%
Return on invested capital
0.02x
Asset turnover
-$10.1M
Cash from operations
$0.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026